antibiotics
The findings confirm that mother’s milk can deliver beneficial bacteria to very-low-birth-weight infants, with feeding practices and antibiotic use influencing this microbial exchange.
The findings of a recent study highlight the potential of the human gut microbiota as a source for new antibiotics.
The findings suggest that while antibiotics can cause changes to the infant microbiota, they are much less significant than the impact of feeding mode.
The findings suggest that artificial intelligence can help uncover new antibiotics, opening the way for new approaches to antibiotic discovery. The work also offers an open-access resource for antibiotic developers.
The findings of a recent study may inform the development of antibiotics that kill harmful bacteria and not beneficial ones.
The findings of a recent study suggest that antimicrobial-resistance mutations in commensal bacteria can make the microbiota surprisingly resilient to antibiotics.
The findings of a recent study suggest that antibiotics should be prescribed with caution in cancer patients who are planning to receive PD-1 inhibitors.
The findings of a recent study suggest that the microbiota-derived metabolite phenyllactic acid can prevent antibiotic-associated obesity in early life.
The findings of a recent study suggest that microbial consortia such as MET-2 may be effective strategies to keep intestinal pathogens and antibiotic-resistant organisms at bay.
Understanding how antibiotics influence the microbiota’s impacts on immunotherapy may inform strategies to identify cancer patients that are more likely to respond to cancer treatment.
